Cost-benefit of stockpiling drugs for influenza pandemic

Ran D. Balicer; Michael Huerta; Nadav Davidovitch; Itamar Grotto

doi:10.3201/eid1108.041156

Cost-benefit of stockpiling drugs for influenza pandemic

Research output: Contribution to journal › Article › peer-review

82 Scopus citations

Abstract

We analyzed strategies for the use of stockpiled antiviral drugs in the context of a future influenza pandemic and estimated cost-benefit ratios. Current stockpiling of oseltamivir appears to be cost-saving to the economy under several treatment strategies, including therapeutic treatment of patients and postexposure prophylactic treatment of patients' close contacts.

Original language	English
Pages (from-to)	1280-1282
Number of pages	3
Journal	Emerging Infectious Diseases
Volume	11
Issue number	8
DOIs	https://doi.org/10.3201/eid1108.041156
State	Published - 1 Jan 2005

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

ASJC Scopus subject areas

Epidemiology
Microbiology (medical)
Infectious Diseases

Access to Document

10.3201/eid1108.041156

Cite this

@article{ebdedcd6bf8044c7bbc68d333fdbc2de,

title = "Cost-benefit of stockpiling drugs for influenza pandemic",

abstract = "We analyzed strategies for the use of stockpiled antiviral drugs in the context of a future influenza pandemic and estimated cost-benefit ratios. Current stockpiling of oseltamivir appears to be cost-saving to the economy under several treatment strategies, including therapeutic treatment of patients and postexposure prophylactic treatment of patients' close contacts.",

author = "Balicer, \{Ran D.\} and Michael Huerta and Nadav Davidovitch and Itamar Grotto",

year = "2005",

month = jan,

day = "1",

doi = "10.3201/eid1108.041156",

language = "English",

volume = "11",

pages = "1280--1282",

journal = "Emerging Infectious Diseases",

issn = "1080-6040",

publisher = "Centers for Disease Control and Prevention (CDC)",

number = "8",

}

TY - JOUR

T1 - Cost-benefit of stockpiling drugs for influenza pandemic

AU - Balicer, Ran D.

AU - Huerta, Michael

AU - Davidovitch, Nadav

AU - Grotto, Itamar

PY - 2005/1/1

Y1 - 2005/1/1

N2 - We analyzed strategies for the use of stockpiled antiviral drugs in the context of a future influenza pandemic and estimated cost-benefit ratios. Current stockpiling of oseltamivir appears to be cost-saving to the economy under several treatment strategies, including therapeutic treatment of patients and postexposure prophylactic treatment of patients' close contacts.

AB - We analyzed strategies for the use of stockpiled antiviral drugs in the context of a future influenza pandemic and estimated cost-benefit ratios. Current stockpiling of oseltamivir appears to be cost-saving to the economy under several treatment strategies, including therapeutic treatment of patients and postexposure prophylactic treatment of patients' close contacts.

UR - https://www.scopus.com/pages/publications/22944469405

U2 - 10.3201/eid1108.041156

DO - 10.3201/eid1108.041156

M3 - Article

C2 - 16102319

AN - SCOPUS:22944469405

SN - 1080-6040

VL - 11

SP - 1280

EP - 1282

JO - Emerging Infectious Diseases

JF - Emerging Infectious Diseases

IS - 8

ER -

Cost-benefit of stockpiling drugs for influenza pandemic

Abstract

UN SDGs

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this